Biosensis offers the highest quality primary antibodies for use in your cancer research. We offer over 70 antibodies that target cancer research including human tumour necrosis factor alpha (TNF alpha), TNF receptor, Cytokeratins, heat shock protein, nestin and matrix metalloproteinases. Biosensis antibodies can be used in many applications including ELISA, western blot (WB) and immunohistochemistry (IHC).

Cancer is a general term that is used to refer to a class of diseases in which a group of cells display uncontrollable growth and invasion of tissue. Most cancers produce a tumour, which can sometimes metastasise to different areas of the body. The study of apoptosis and cancer are quite closely linked because in the disease state the cancer cells have found a way to avoid apoptosis. P53 is an important transcription factor involved in the cell cycle and research into this pathway is a very important area of anti-cancer research. Biosensis offers a range of cell cycle regulator antibodies including a p53 antibody.